אולנזאפין דקסל 5 מ"ג

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

OLANZAPINE 5 MG

Pieejams no:

DEXCEL PHARMA TECHNOLOGIES LTD

ATĶ kods:

N05AH03

Zāļu forma:

TABLETS

Ievadīšanas:

PER OS

Ražojis:

DEXCEL LTD

Ārstniecības grupa:

OLANZAPINE

Ārstēšanas norādes:

Acute and maintenance treatment of schizophrenia. Olanzapine is indicated for the management of the manifestations of psychotic disorders. Olanzapine is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Autorizācija datums:

2012-05-01